Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03024827
What this trial is testing

Cannabidiol in Children With Refractory Epileptic Encephalopathy

Who this might be right for
Epileptic Encephalopathy
University of Saskatchewan 20
Testing effectiveness (Phase 2)WithdrawnNCT00567424
What this trial is testing

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
Epilepsy
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00988429
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 653
Large-scale testing (Phase 3)Study completedNCT03572933
What this trial is testing

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder

Who this might be right for
CDKL5 Deficiency Disorder
Marinus Pharmaceuticals 101
Large-scale testing (Phase 3)WithdrawnNCT02726867
What this trial is testing

Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

Who this might be right for
EpilepsyStatus Epilepticus
Mid-Atlantic Epilepsy and Sleep Center, LLC
Large-scale testing (Phase 3)Ended earlyNCT02431663
What this trial is testing

Ketamine in Refractory Convulsive Status Epilepticus

Who this might be right for
Status Epilepticus
Meyer Children's Hospital IRCCS 57
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT02914314
What this trial is testing

Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Who this might be right for
Epilepsy
Eisai Inc. 26
Not applicableEnded earlyNCT02820740
What this trial is testing

Feasibility Study on LITT for Medical Refractory Epilepsy

Who this might be right for
Epilepsy
Monteris Medical 4
Testing effectiveness (Phase 2)Ended earlyNCT02474407
What this trial is testing

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

Who this might be right for
Refractory Epilepsy
Acorda Therapeutics 78
Testing effectiveness (Phase 2)Study completedNCT00236860
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 56
Large-scale testing (Phase 3)Study completedNCT00699972
What this trial is testing

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 390
Large-scale testing (Phase 3)Ended earlyNCT01769092
What this trial is testing

Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders

Who this might be right for
Epilepsy (Treatment Refractory)
The Canadian College of Naturopathic Medicine 6
Post-approval studies (Phase 4)Study completedNCT01229735
What this trial is testing

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Korea Co., Ltd. 343
Testing effectiveness (Phase 2)Study completedNCT01159431
What this trial is testing

External Trigeminal Nerve Stimulation for Epilepsy

Who this might be right for
EpilepsySeizure Disorders
Olive View-UCLA Education & Research Institute 50
Large-scale testing (Phase 3)Study completedNCT00026637
What this trial is testing

Depression and Health Outcomes in Refractory Epilepsy

Who this might be right for
DepressionEpilepsy
Columbia University 140
Testing effectiveness (Phase 2)Study completedNCT00236847
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60
Not applicableStudy completedNCT00071305
What this trial is testing

Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 35
Not applicableEnrolling By InvitationNCT07353918
What this trial is testing

Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy

Who this might be right for
Epilepsy (Treatment Refractory)Epilepsy Comorbidities
Carilion Clinic 6
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Next Page